Correlation between Physical Status of Human Papilloma Virus and Cervical Carcinogenesis
The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer,the physical status of HPV-16 in patients with cervical lesions,and the role of HPV-16 integration in cervi-cal carcinogenesis were investigated.HPV genotyping was performed by using PCR approach with the primer GP5+/G...
        Saved in:
      
    
          | Published in | Journal of Huazhong University of Science and Technology. Medical sciences Vol. 32; no. 1; pp. 97 - 102 | 
|---|---|
| Main Author | |
| Format | Journal Article | 
| Language | English | 
| Published | 
        Heidelberg
          Huazhong University of Science and Technology
    
        01.02.2012
     | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 1672-0733 1993-1352  | 
| DOI | 10.1007/s11596-012-0017-7 | 
Cover
| Abstract | The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer,the physical status of HPV-16 in patients with cervical lesions,and the role of HPV-16 integration in cervi-cal carcinogenesis were investigated.HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women.Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection,includ-ing 112 specimens with cervical cancer,151 specimens with CINⅠ,246 specimens with CINⅡ and 120 specimens with CINⅢ.The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection.The frequency of HPV-16 pure integration was 65.18% (73/112),56.57% (47/120),23.58% (58/246) and 7.95% (12/151) in cervical cancer,CINⅢ,CINⅡand CINⅠ patients respectively.In situ hybridization was performed on some paraffin-embedded sections of CINⅡ,CINⅢ and cervical cancer to verify the physical status of HPV-16 infection.Sig-nificant difference was observed between cervical cancer and CINⅠ,CINⅡ,CINⅢ in the frequency of HPV-16 integration (P0.01).It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer.In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration.The application of testing HPV genotyping and physical status based on detection of HC-Ⅱ HPV DNA would be in favor of predicting the progno-sis of cervical precancerosis and enhancing the screening accuracy of cervical cancer. | 
    
|---|---|
| AbstractList | The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN and 120 specimens with CINIII. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CINIII, CINII and CINI patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CINII, CINIII and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CINII, CINIII in the frequency of HPV-16 integration (P<0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC-II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer. The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN II and 120 specimens with CIN III. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CIN III, CIN II and CIN I patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CIN II, CIN III and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CIN II, CIN III in the frequency of HPV-16 integration (P<0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC- II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer. The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer,the physical status of HPV-16 in patients with cervical lesions,and the role of HPV-16 integration in cervi-cal carcinogenesis were investigated.HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women.Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection,includ-ing 112 specimens with cervical cancer,151 specimens with CINⅠ,246 specimens with CINⅡ and 120 specimens with CINⅢ.The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection.The frequency of HPV-16 pure integration was 65.18% (73/112),56.57% (47/120),23.58% (58/246) and 7.95% (12/151) in cervical cancer,CINⅢ,CINⅡand CINⅠ patients respectively.In situ hybridization was performed on some paraffin-embedded sections of CINⅡ,CINⅢ and cervical cancer to verify the physical status of HPV-16 infection.Sig-nificant difference was observed between cervical cancer and CINⅠ,CINⅡ,CINⅢ in the frequency of HPV-16 integration (P0.01).It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer.In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration.The application of testing HPV genotyping and physical status based on detection of HC-Ⅱ HPV DNA would be in favor of predicting the progno-sis of cervical precancerosis and enhancing the screening accuracy of cervical cancer. The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN and 120 specimens with CINIII. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CINIII, CINII and CINI patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CINII, CINIII and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CINII, CINIII in the frequency of HPV-16 integration (P<0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC-II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer.The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN and 120 specimens with CINIII. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CINIII, CINII and CINI patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CINII, CINIII and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CINII, CINIII in the frequency of HPV-16 integration (P<0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC-II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer. Summary The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the role of HPV-16 integration in cervical carcinogenesis were investigated. HPV genotyping was performed by using PCR approach with the primer GP5+/GP6+ and type-specific primer on biopsy specimens taken operatively from 198 women. Multiple PCR was done to detect physical status of HPV-16 in a series of cervical liquid-based cytology samples and biopsy specimens obtained from different cervical lesions with HPV-16 infection, including 112 specimens with cervical cancer, 151 specimens with CIN I, 246 specimens with CIN and 120 specimens with CINIII. The results showed that there were 112 cervical cancer samples (56.57% of total cervical cancer patients) with HPV-16 infection. The frequency of HPV-16 pure integration was 65.18% (73/112), 56.57% (47/120), 23.58% (58/246) and 7.95% (12/151) in cervical cancer, CINIII, CINII and CINI patients respectively. In situ hybridization was performed on some paraffin-embedded sections of CINII, CINIII and cervical cancer to verify the physical status of HPV-16 infection. Significant difference was observed between cervical cancer and CIN I, CINII, CINIII in the frequency of HPV-16 integration ( P <0.01). It is suggested that HPV-16 is the most prevalent type and is associated with cervical cancer. In the case of HPV-16 infection there are close associations between the severity of cervical lesions and the frequency of HPV-16 integration. The application of testing HPV genotyping and physical status based on detection of HC-II HPV DNA would be in favor of predicting the prognosis of cervical precancerosis and enhancing the screening accuracy of cervical cancer.  | 
    
| Author | 李科珍 金鑫 方勇 王常玉 龚妹 陈平波 刘佳 邓东锐 艾继辉 | 
    
| AuthorAffiliation | Cancer | 
    
| Author_xml | – sequence: 1 fullname: 李科珍 金鑫 方勇 王常玉 龚妹 陈平波 刘佳 邓东锐 艾继辉  | 
    
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22282253$$D View this record in MEDLINE/PubMed | 
    
| BookMark | eNp9kUtr3DAUhUVIaR7tD8gmGLpINm71lrUspnlAoIWG0p2Q5euJgi1NJDsl_z5KZgKhi1lJ6HznXnTOEdoPMQBCJwR_JRirb5kQoWWNCa0xJqpWe-iQaM1qwgTdL3epiqIYO0BHOd9jLJSk_CM6oJQ2lAp2iP62MSUY7exjqDqY_wGE6tfdU_bOjtXv2c5LruJQXS2TLYJd-3GMk63--FQEG_qqhfT4Crc2OR_iCgJknz-hD4MdM3zensfo9uLHbXtV3_y8vG6_39SOYz7XrHMdcUwqSySXnON-6EFTEFRyTERT3pRwrBOssxooNK6XcpBNEbWTgh2js83YdYoPC-TZTD47GEcbIC7ZaNIIJQjFhTzfSRJMccM1J7qgp1t06SbozTr5yaYn8xZbAdQGcCnmnGAwzs-vGc7J-rHMMi8FmU1BphRkXgoyqjjJf8634bs8dOPJhQ0rSOY-LimUVHeavmwX3cWweii-d5vKV7FSjWDPOXGsTw | 
    
| CitedBy_id | crossref_primary_10_1007_s11596_018_1868_3 crossref_primary_10_3390_pathogens9090685 crossref_primary_10_1016_j_envres_2020_109465 crossref_primary_10_1007_s10330_015_0092_x crossref_primary_10_1158_1078_0432_CCR_12_1983 crossref_primary_10_1016_j_meegid_2018_03_003 crossref_primary_10_1007_s11596_013_1189_5 crossref_primary_10_1016_j_radonc_2013_06_004 crossref_primary_10_2174_1389557523666230213140641 crossref_primary_10_1038_s41598_025_93358_x  | 
    
| Cites_doi | 10.2217/fvl.10.73 10.1128/JCM.44.5.1755-1762.2006 10.1099/jmm.0.019240-0 10.1158/1055-9965.EPI-09-0025 10.1038/sj.bjc.6602648 10.1158/0008-5472.CAN-07-6862 10.1158/0008-5472.CAN-04-0009 10.1128/JCM.44.4.1310-1317.2006 10.1128/JVI.02093-10 10.1002/path.2192 10.1016/j.vaccine.2008.06.021 10.1007/s00428-009-0823-x 10.1016/j.ygyno.2008.12.004 10.1038/sj.bjc.6601691 10.1016/j.jviromet.2009.01.005 10.1136/mp.53.4.201 10.1128/JCM.01212-08 10.1016/j.ygyno.2004.08.025 10.1128/JCM.35.3.791-795.1997  | 
    
| ContentType | Journal Article | 
    
| Copyright | Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2012 | 
    
| Copyright_xml | – notice: Huazhong University of Science and Technology and Springer-Verlag Berlin Heidelberg 2012 | 
    
| DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7U9 H94 7X8  | 
    
| DOI | 10.1007/s11596-012-0017-7 | 
    
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic  | 
    
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Virology and AIDS Abstracts MEDLINE - Academic  | 
    
| DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic  | 
    
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database  | 
    
| DeliveryMethod | fulltext_linktorsrc | 
    
| Discipline | Medicine | 
    
| EISSN | 1993-1352 | 
    
| EndPage | 102 | 
    
| ExternalDocumentID | 22282253 10_1007_s11596_012_0017_7 1002007785  | 
    
| Genre | Research Support, Non-U.S. Gov't Journal Article  | 
    
| GeographicLocations | China | 
    
| GeographicLocations_xml | – name: China | 
    
| GroupedDBID | -5E -5G -BR -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 29K 29~ 2B. 2C~ 2J2 2KG 2KM 2LR 2RA 2~H 30V 4.4 408 40D 40E 53G 5GY 5VS 6NX 8TC 8UJ 92F 92I 92L 95- 95. 95~ 96X AAAVM AABHQ AAJKR AANXM AARHV AARTL AAYIU AAYQN AAYTO ABFTV ABJNI ABJOX ABKCH ABMNI ABNWP ABQBU ABTMW ACGFS ACHXU ACKNC ACOMO ACSNA ACUDM ADHIR ADINQ ADKPE ADURQ ADYFF ADZKW AEBTG AEGNC AEJHL AEKMD AEOHA AEPYU AETLH AEXYK AFWTZ AFZKB AGAYW AGDGC AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHYZX AIIXL AJBLW AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP ARMRJ AZFZN B-. BA0 BGNMA CAG CCEZO CHBEP CIEJG COF CQIGP CS3 CSCUP CW9 D-I DPUIP EBS EJD ESBYG FA0 FEDTE FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GQ6 GQ7 HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IXD I~X I~Z J-C JBSCW JUIAU KOV M4Y MA- N2Q NDZJH NQJWS NU0 O9- O93 O9I O9J P9S PF0 QOR QOS R-E R89 R9I RIG ROL RPX RSV S.. S16 S1Z S27 S37 S3B SAP SCL SDH SHX SMD SNE SNX SOJ SPISZ SZ9 SZN T13 TCJ TSG TT1 TUC U2A U9L UG4 VC2 W48 W91 WK8 Z7U Z82 Z8V ZOVNA ~A9 ~WA ABQSL H13 AAYXX ADHKG AGQPQ CITATION CGR CUY CVF ECM EIF NPM 7U9 H94 7X8  | 
    
| ID | FETCH-LOGICAL-c404t-3bcb1c367a1646440dfde92e5264015846475c3b53ba9e2e8cd66f684019c653 | 
    
| IEDL.DBID | U2A | 
    
| ISSN | 1672-0733 | 
    
| IngestDate | Fri Sep 05 10:39:02 EDT 2025 Fri Sep 05 05:58:42 EDT 2025 Thu Jan 02 23:11:22 EST 2025 Thu Apr 24 23:10:07 EDT 2025 Wed Oct 01 00:35:56 EDT 2025 Fri Feb 21 02:37:16 EST 2025 Wed Feb 14 10:42:25 EST 2024  | 
    
| IsPeerReviewed | false | 
    
| IsScholarly | false | 
    
| Issue | 1 | 
    
| Keywords | integration physical status human papilloma virus cervical cancer genotyping  | 
    
| Language | English | 
    
| License | http://www.springer.com/tdm | 
    
| LinkModel | DirectLink | 
    
| MergedId | FETCHMERGED-LOGICAL-c404t-3bcb1c367a1646440dfde92e5264015846475c3b53ba9e2e8cd66f684019c653 | 
    
| Notes | 42-1679/R ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2  | 
    
| PMID | 22282253 | 
    
| PQID | 1020849419 | 
    
| PQPubID | 23462 | 
    
| PageCount | 6 | 
    
| ParticipantIDs | proquest_miscellaneous_918575120 proquest_miscellaneous_1020849419 pubmed_primary_22282253 crossref_citationtrail_10_1007_s11596_012_0017_7 crossref_primary_10_1007_s11596_012_0017_7 springer_journals_10_1007_s11596_012_0017_7 chongqing_primary_1002007785  | 
    
| ProviderPackageCode | CITATION AAYXX  | 
    
| PublicationCentury | 2000 | 
    
| PublicationDate | 2012-02-01 | 
    
| PublicationDateYYYYMMDD | 2012-02-01 | 
    
| PublicationDate_xml | – month: 02 year: 2012 text: 2012-02-01 day: 01  | 
    
| PublicationDecade | 2010 | 
    
| PublicationPlace | Heidelberg | 
    
| PublicationPlace_xml | – name: Heidelberg – name: China  | 
    
| PublicationSubtitle | Medical Sciences | 
    
| PublicationTitle | Journal of Huazhong University of Science and Technology. Medical sciences | 
    
| PublicationTitleAbbrev | J. Huazhong Univ. Sci. Technol. [Med. Sci.] | 
    
| PublicationTitleAlternate | Journal of Zuazhong University of Science and Technology: Medical Sciences | 
    
| PublicationYear | 2012 | 
    
| Publisher | Huazhong University of Science and Technology | 
    
| Publisher_xml | – name: Huazhong University of Science and Technology | 
    
| References | Giuliano (CR19) 2008; 26 Jacobs, Snijders, Walboomers (CR9) 1997; 35 Michael, James, Jens (CR20) 2011; 85 Andersson, Safari, Mints (CR6) 2005; 92 CR13 Vonetta, Maria, Ubaldo (CR15) 2011; 6 Nambaru, Meenakumari, Swaminthan (CR17) 2009; 10 Graham, Herrington (CR12) 2000; 53 Boulet, Benoy, Depuydt (CR26) 2009; 18 Sathish, Abraham, Sridharan (CR25) 2004; 95 Cricca, Venturoli, Leo (CR23) 2009; 158 Yoshida, Sano, Oyama (CR22) 2009; 455 Kraus, Molden, Holm (CR10) 2006; 44 Rao, Wang, Fan (CR1) 2011; 40 Saunier, Monnier-Benoit, Mauny (CR24) 2008; 46 Shukla, Bharti, Mahata (CR21) 2010; 59 Moore, Chang (CR3) 2010; 10 Narisawa-Saito, Yoshimatsu, Ohno (CR5) 2008; 68 Matovina, Sabol, Grubišić (CR4) 2009; 113 Pett, Coleman (CR8) 2007; 212 Dong, Li, Wang (CR2) 2010; 39 Huang, Zhou, Xu (CR14) 2009; 13 Wentzensen, Vinokurova, Knebel (CR7) 2004; 64 Ding, Tian, Wu (CR16) 2010; 24 Kraus, Molden, Erno (CR11) 2004; 90 Arias-Pulido, Peyton, Joste (CR18) 2006; 44 M. Cricca (17_CR23) 2009; 158 J.L. Michael (17_CR20) 2011; 85 A.R. Giuliano (17_CR19) 2008; 26 17_CR13 T. Yoshida (17_CR22) 2009; 455 H. Arias-Pulido (17_CR18) 2006; 44 M. Narisawa-Saito (17_CR5) 2008; 68 N. Wentzensen (17_CR7) 2004; 64 G.A.V. Boulet (17_CR26) 2009; 18 H. Dong (17_CR2) 2010; 39 M.V. Jacobs (17_CR9) 1997; 35 Y.M. Rao (17_CR1) 2011; 40 I. Kraus (17_CR11) 2004; 90 S. Andersson (17_CR6) 2005; 92 W.C. Ding (17_CR16) 2010; 24 M. Saunier (17_CR24) 2008; 46 M.W. Vonetta (17_CR15) 2011; 6 P.S. Moore (17_CR3) 2010; 10 S. Shukla (17_CR21) 2010; 59 D.A. Graham (17_CR12) 2000; 53 M. Matovina (17_CR4) 2009; 113 B.Y. Huang (17_CR14) 2009; 13 N. Sathish (17_CR25) 2004; 95 I. Kraus (17_CR10) 2006; 44 M. Pett (17_CR8) 2007; 212 L. Nambaru (17_CR17) 2009; 10 18847554 - Vaccine. 2008 Aug 19;26 Suppl 10:K17-28 17573670 - J Pathol. 2007 Aug;212(4):356-67 16672403 - J Clin Microbiol. 2006 May;44(5):1755-62 16597856 - J Clin Microbiol. 2006 Apr;44(4):1310-7 15942630 - Br J Cancer. 2005 Jun 20;92(12):2195-200 15054464 - Br J Cancer. 2004 Apr 5;90(7):1407-13 19861526 - Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2992-9 18799702 - J Clin Microbiol. 2008 Nov;46(11):3678-85 21123375 - J Virol. 2011 Feb;85(4):1645-54 11040943 - Mol Pathol. 2000 Aug;53(4):201-6 15491758 - Gynecol Oncol. 2004 Nov;95(2):363-9 19727809 - Virchows Arch. 2009 Sep;455(3):253-9 20688948 - J Med Microbiol. 2010 Nov;59(Pt 11):1303-10 9041439 - J Clin Microbiol. 1997 Mar;35(3):791-5 19640172 - Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):355-60 15172997 - Cancer Res. 2004 Jun 1;64(11):3878-84 19187786 - J Virol Methods. 2009 Jun;158(1-2):180-3 21102637 - Nat Rev Cancer. 2010 Dec;10(12):878-89 19157528 - Gynecol Oncol. 2009 Apr;113(1):120-7 21318095 - Future Virol. 2011 Jan 1;6(1):45-57 18632622 - Cancer Res. 2008 Jul 15;68(14):5699-705  | 
    
| References_xml | – volume: 6 start-page: 45 issue: 1 year: 2011 end-page: 57 ident: CR15 article-title: HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress publication-title: Future Virol doi: 10.2217/fvl.10.73 – volume: 10 start-page: 355 year: 2009 end-page: 360 ident: CR17 article-title: Prognostic significance of HPV physical status and integration sites in cervical cancer publication-title: Asian Pacific J Cancer Prev – volume: 44 start-page: 1755 issue: 5 year: 2006 end-page: 1762 ident: CR18 article-title: Human papillomavirus type 16 integration in cervical carcinoma , and in invasive cervical cancer publication-title: J Clin Microbiol doi: 10.1128/JCM.44.5.1755-1762.2006 – volume: 59 start-page: 1303 issue: Pt11 year: 2010 end-page: 1310 ident: CR21 article-title: Application of a multiplex PCR to cervical cells collected by a paper smear for the simultaneous detection of all mucosal human papillomaviruses (HPVs) and typing of high-risk HPV types 16 and 18 publication-title: J Med Microbiol doi: 10.1099/jmm.0.019240-0 – volume: 18 start-page: 2992 issue: 11 year: 2009 end-page: 2999 ident: CR26 article-title: Human papillomavirus 16 load and E2/E6 ratio in HPV-16-positive women: biomarkers for cervical intraepithelial neoplasia ≥2 in a lLiquid-based cytology setting? publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-09-0025 – volume: 40 start-page: 32 issue: 1 year: 2011 end-page: 36 ident: CR1 article-title: Effects of MTA1 gene transfection on adhesion, migration and invasiveness of Hela cells by altered expression of MMP29 and β-catenin publication-title: Acta Med Univ Sci Technol Huazhong (Chinese) – volume: 92 start-page: 2195 year: 2005 end-page: 2200 ident: CR6 article-title: Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN) publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602648 – volume: 68 start-page: 5699 issue: 14 year: 2008 end-page: 5705 ident: CR5 article-title: An , multistep carcinogenesis model for human cervical cancer publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-6862 – volume: 64 start-page: 3878 issue: 11 year: 2004 end-page: 3884 ident: CR7 article-title: Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-0009 – volume: 44 start-page: 1310 issue: 4 year: 2006 end-page: 1317 ident: CR10 article-title: Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas publication-title: J Clin Microbiol doi: 10.1128/JCM.44.4.1310-1317.2006 – volume: 85 start-page: 1645 issue: 4 year: 2011 end-page: 1654 ident: CR20 article-title: Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers publication-title: J Virol doi: 10.1128/JVI.02093-10 – volume: 212 start-page: 356 issue: 4 year: 2007 end-page: 367 ident: CR8 article-title: Integration of high-risk human papillomavirus: a key event in carcinogenesis? publication-title: J Pathol doi: 10.1002/path.2192 – volume: 39 start-page: 254 issue: 2 year: 2010 end-page: 257 ident: CR2 article-title: Comparison of the biological behaviors and prognostic factors in cervical adenocarcinoma and squamous carcinoma publication-title: Acta Med Univ Sci Technol Huazhong (Chinese) – volume: 26 start-page: K17 issue: S10 year: 2008 end-page: K28 ident: CR19 article-title: Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions publication-title: Vaccine doi: 10.1016/j.vaccine.2008.06.021 – volume: 455 start-page: 253 issue: 3 year: 2009 end-page: 259 ident: CR22 article-title: Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma publication-title: Virchows Arch doi: 10.1007/s00428-009-0823-x – volume: 13 start-page: 1065 issue: 8 year: 2009 end-page: 1067 ident: CR14 article-title: Study on the detecting genotypes of human papillomavirus infection by using flow-through hybridization and gene chip publication-title: Chin J Lab Diagn (Chinese) – volume: 24 start-page: 3390 year: 2010 end-page: 3392 ident: CR16 article-title: Analysis on infection status of cervical human papillomavirus in 3753 women publication-title: Zhongguo Fuyou Baojian (Chinese) – volume: 113 start-page: 120 year: 2009 end-page: 127 ident: CR4 article-title: Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2008.12.004 – volume: 90 start-page: 1407 issue: 7 year: 2004 end-page: 1413 ident: CR11 article-title: Human papillomavirus oncogenic expression in the dysplasticportic portio; an investigation of biopsies from 190 cervical cones publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601691 – volume: 158 start-page: 180 issue: 1–2 year: 2009 end-page: 183 ident: CR23 article-title: Disruption of HPV-16 E1 and E2 genes in precancerous cervical lesions publication-title: J Virol Met doi: 10.1016/j.jviromet.2009.01.005 – volume: 35 start-page: 791 issue: 3 year: 1997 end-page: 795 ident: CR9 article-title: A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings publication-title: J Clin Microbiol – volume: 53 start-page: 201 issue: 4 year: 2000 end-page: 206 ident: CR12 article-title: HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities publication-title: Mol Pathol doi: 10.1136/mp.53.4.201 – volume: 10 start-page: 878 issue: 12 year: 2010 end-page: 889 ident: CR3 article-title: Why do viruses cause cancer? Highlights of the first century of human tumor virology publication-title: Nature – ident: CR13 – volume: 46 start-page: 3678 issue: 11 year: 2008 end-page: 3685 ident: CR24 article-title: Analysis of human papillomavirus type 16 (HPV-16) DNA load and physical state for identification of HPV-16-infected women with high-grade lesions or cervical carcinoma publication-title: J Clin Microbiol doi: 10.1128/JCM.01212-08 – volume: 95 start-page: 363 issue: 2 year: 2004 end-page: 369 ident: CR25 article-title: E2 sequence variations of HPV-16 among patients with cervical neoplasia seen in the Indian subcontinent publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2004.08.025 – volume: 46 start-page: 3678 issue: 11 year: 2008 ident: 17_CR24 publication-title: J Clin Microbiol doi: 10.1128/JCM.01212-08 – volume: 26 start-page: K17 issue: S10 year: 2008 ident: 17_CR19 publication-title: Vaccine doi: 10.1016/j.vaccine.2008.06.021 – volume: 44 start-page: 1755 issue: 5 year: 2006 ident: 17_CR18 publication-title: J Clin Microbiol doi: 10.1128/JCM.44.5.1755-1762.2006 – volume: 90 start-page: 1407 issue: 7 year: 2004 ident: 17_CR11 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601691 – volume: 113 start-page: 120 year: 2009 ident: 17_CR4 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2008.12.004 – volume: 68 start-page: 5699 issue: 14 year: 2008 ident: 17_CR5 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-6862 – volume: 44 start-page: 1310 issue: 4 year: 2006 ident: 17_CR10 publication-title: J Clin Microbiol doi: 10.1128/JCM.44.4.1310-1317.2006 – volume: 92 start-page: 2195 year: 2005 ident: 17_CR6 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602648 – volume: 10 start-page: 355 year: 2009 ident: 17_CR17 publication-title: Asian Pacific J Cancer Prev – volume: 24 start-page: 3390 year: 2010 ident: 17_CR16 publication-title: Zhongguo Fuyou Baojian (Chinese) – volume: 10 start-page: 878 issue: 12 year: 2010 ident: 17_CR3 publication-title: Nature – volume: 85 start-page: 1645 issue: 4 year: 2011 ident: 17_CR20 publication-title: J Virol doi: 10.1128/JVI.02093-10 – volume: 35 start-page: 791 issue: 3 year: 1997 ident: 17_CR9 publication-title: J Clin Microbiol doi: 10.1128/JCM.35.3.791-795.1997 – volume: 39 start-page: 254 issue: 2 year: 2010 ident: 17_CR2 publication-title: Acta Med Univ Sci Technol Huazhong (Chinese) – ident: 17_CR13 – volume: 40 start-page: 32 issue: 1 year: 2011 ident: 17_CR1 publication-title: Acta Med Univ Sci Technol Huazhong (Chinese) – volume: 6 start-page: 45 issue: 1 year: 2011 ident: 17_CR15 publication-title: Future Virol doi: 10.2217/fvl.10.73 – volume: 18 start-page: 2992 issue: 11 year: 2009 ident: 17_CR26 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-09-0025 – volume: 53 start-page: 201 issue: 4 year: 2000 ident: 17_CR12 publication-title: Mol Pathol doi: 10.1136/mp.53.4.201 – volume: 455 start-page: 253 issue: 3 year: 2009 ident: 17_CR22 publication-title: Virchows Arch doi: 10.1007/s00428-009-0823-x – volume: 158 start-page: 180 issue: 1–2 year: 2009 ident: 17_CR23 publication-title: J Virol Met doi: 10.1016/j.jviromet.2009.01.005 – volume: 64 start-page: 3878 issue: 11 year: 2004 ident: 17_CR7 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-04-0009 – volume: 13 start-page: 1065 issue: 8 year: 2009 ident: 17_CR14 publication-title: Chin J Lab Diagn (Chinese) – volume: 59 start-page: 1303 issue: Pt11 year: 2010 ident: 17_CR21 publication-title: J Med Microbiol doi: 10.1099/jmm.0.019240-0 – volume: 212 start-page: 356 issue: 4 year: 2007 ident: 17_CR8 publication-title: J Pathol doi: 10.1002/path.2192 – volume: 95 start-page: 363 issue: 2 year: 2004 ident: 17_CR25 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2004.08.025 – reference: 16597856 - J Clin Microbiol. 2006 Apr;44(4):1310-7 – reference: 16672403 - J Clin Microbiol. 2006 May;44(5):1755-62 – reference: 9041439 - J Clin Microbiol. 1997 Mar;35(3):791-5 – reference: 11040943 - Mol Pathol. 2000 Aug;53(4):201-6 – reference: 21318095 - Future Virol. 2011 Jan 1;6(1):45-57 – reference: 19727809 - Virchows Arch. 2009 Sep;455(3):253-9 – reference: 15172997 - Cancer Res. 2004 Jun 1;64(11):3878-84 – reference: 15942630 - Br J Cancer. 2005 Jun 20;92(12):2195-200 – reference: 15491758 - Gynecol Oncol. 2004 Nov;95(2):363-9 – reference: 17573670 - J Pathol. 2007 Aug;212(4):356-67 – reference: 20688948 - J Med Microbiol. 2010 Nov;59(Pt 11):1303-10 – reference: 19861526 - Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2992-9 – reference: 21102637 - Nat Rev Cancer. 2010 Dec;10(12):878-89 – reference: 19640172 - Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):355-60 – reference: 18847554 - Vaccine. 2008 Aug 19;26 Suppl 10:K17-28 – reference: 19157528 - Gynecol Oncol. 2009 Apr;113(1):120-7 – reference: 18799702 - J Clin Microbiol. 2008 Nov;46(11):3678-85 – reference: 19187786 - J Virol Methods. 2009 Jun;158(1-2):180-3 – reference: 15054464 - Br J Cancer. 2004 Apr 5;90(7):1407-13 – reference: 21123375 - J Virol. 2011 Feb;85(4):1645-54 – reference: 18632622 - Cancer Res. 2008 Jul 15;68(14):5699-705  | 
    
| SSID | ssj0057624 | 
    
| Score | 1.5587884 | 
    
| Snippet | The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer,the physical status of HPV-16 in patients with cervical lesions,and the role... Summary The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and... The prevalence of human papilloma virus (HPV)-16 in patients with cervical cancer, the physical status of HPV-16 in patients with cervical lesions, and the...  | 
    
| SourceID | proquest pubmed crossref springer chongqing  | 
    
| SourceType | Aggregation Database Index Database Enrichment Source Publisher  | 
    
| StartPage | 97 | 
    
| SubjectTerms | Adult Aged Biopsy cancer;genotyping;physical Carcinogenesis Cervical cancer Cervix China Female Genotyping human Human papillomavirus Human papillomavirus 16 - genetics Human papillomavirus 16 - isolation & purification Humans Infection Integration Medicine Medicine & Public Health Middle Aged papilloma Papillomavirus Infections - diagnosis Papillomavirus Infections - virology Polymerase chain reaction Precancerous Conditions - diagnosis Precancerous Conditions - virology Primers Prognosis Risk Factors Statistics as Topic status;integration Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - virology virus;cervical  | 
    
| Title | Correlation between Physical Status of Human Papilloma Virus and Cervical Carcinogenesis | 
    
| URI | http://lib.cqvip.com/qk/85740A/201201/1002007785.html https://link.springer.com/article/10.1007/s11596-012-0017-7 https://www.ncbi.nlm.nih.gov/pubmed/22282253 https://www.proquest.com/docview/1020849419 https://www.proquest.com/docview/918575120  | 
    
| Volume | 32 | 
    
| hasFullText | 1 | 
    
| inHoldings | 1 | 
    
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1993-1352 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0057624 issn: 1672-0733 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1993-1352 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0057624 issn: 1672-0733 databaseCode: U2A dateStart: 20020101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature  | 
    
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT-MwEB4tICEuK94EWGQkTqBIie3YybFCsAjEnkAqp8hxHKhUktK0-_uZyaPViu2BcyZ25LFnvnhmvgG4kOiUBHoev-C28BHfhj46QeMHRhVCCFuEAdUOP_5Rd8_yfhgNuzruus9270OSjaVeFruh56W_X-43plWvwUZEbF64iZ_5oDe_iJ_bTrZKU1qlEH0o839DEKHCW1W-fuB0_zqmL2jzS6S0cUC32_CzQ45s0Kp6B364chc2H7vY-B4Mr6nRRpvaxrr0Kzbp1MCocGhes6pgTVc-NjGT0XhcvRv2dzTFB6bMmW3sBgpbajBUVq9kB0f1Pjzd3jxd3_ld3wTfykDOfJHZLLRCaUPkYVIGeZG7hLsIwQ96f0QcUkdWZJHITOK4i22uVEGsL2FiVSQOYL2sSncETOdJkEseKk60YzwxMVpDzaVTJoxdrjw4XaxfOmnpMYgFmS5AdRx5EPRLmtqOcpw6X4zTJVkyaSRFjVBynU61B5eLV5YDrhQ-7_WU4qmgUIcpXTWvUZ4HsUxkmHjAVsgkRIOFeCfw4LDV8WJGuhZDQyc8uOqVnnZnu179Ocffkj6BLd7sREqNOYX12XTufiHAmWVnsDH4_fJwc9Zs7E_bA_AO | 
    
| linkProvider | Springer Nature | 
    
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7BVgIuvB-BAkbiBEqV2I6dHKuqZaHdnhZpOUWO47QrlmRpdjnw65lJnF1B2UPPmdiOx5754hl_A_BeolMS6HnCitsqRHwbh-gETRgZVQkhbBVHdHd4cq7GX-WXWTLz97jbIdt9CEl2lnp72Q09L_398rAzrfo27En8P-Ej2Dv89O30eDDAiKD7WrZKU2KlEEMw83-NEKXCZVNf_MQO_3ZN1_DmtVhp54JOHsB0GHyfefL9YL0qDuzvf3gdb_h1D-G-h6TssF9Dj-CWqx_DnYkPuj-B2RFV8Ohz5pjP62JLr19GN5LWLWsq1pX7Y0uznC8WzQ_Dfs2v8IGpS2Y7g4TClioX1c0FGdh5-xSmJ8fTo3HoCzKEVkZyFYrCFrEVShtiJZMyKqvSZdwliKoQViCUkTqxokhEYTLHXWpLpSqik4kzqxLxDEZ1U7sXwHSZRaXkseLEZ8Yzk6KZ1Vw6ZeLUlSqA_Y1a8mXPu0H0ynSyqtMkgGjQVG49lzmV1FjkWxZmms8c55Oy9nSuA_iweWXb4E7hd4P6c9xuFEMxtWvWLcrzKJWZjLMA2A6ZjPi1EEhFATzvl86mRzpvQwsqAvg4LIPcG41293Be3kj6LdwdTydn-dnn89NXcI93a4ryb_ZhtLpau9eIolbFG79r_gAvVQ40 | 
    
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDCa2DCh2Kdo93cemATttMGpLsmQfi3ZB92ixQwLkZsiy3AbIbDdO-vtL-pFg6HLY2bRkiBL5WSQ_AnyW6JQEeh6_4LbwEd-GPjpB4wdGFUIIW4QB1Q5f36irqfwxi2Z9n9NmyHYfQpJdTQOxNJWrszovzraFb-iF6U-Y-62Z1c_hhSSeBNzQU34-mGLE0l1XW6UpxVKIIaz5ryGIXOGuKm_vceq_ndQT5Pkkato6o_EB7Pcokp13aj-EZ658BXvXfZz8NcwuqOlGl-bG-lQsVvcqYVREtG5YVbC2Qx-rTT1fLKo_hj3Ml_jAlDmzrQ1BYUvNhsrqlmzivHkDk_G3ycWV3_dQ8K0M5MoXmc1CK5Q2RCQmZZAXuUu4ixAIIRJA9CF1ZEUWicwkjrvY5koVxAATJlZF4i2Myqp074HpPAlyyUPFiYKMJyZGy6i5dMqEscuVByeb9UvrjiqDGJHpMlTHkQfBsKSp7enHqQvGIt0SJ5NGUtQIJdrpVHvwZfPKdsCdwp8GPaV4QijsYUpXrRuU50EsExkmHrAdMglRYiH2CTx41-l4MyNdkaHREx58HZSe9ue82f05R_8l_RH2fl-O01_fb34ew0vebkrKmDmB0Wq5dqeIe1bZh3ZvPwK8F_Wi | 
    
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+between+Physical+Status+of+Human+Papilloma+Virus+and+Cervical+Carcinogenesis&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Li%2C+K&rft.au=Jin%2C+X&rft.au=Fang%2C+Y&rft.au=Wang%2C+C&rft.date=2012-02-01&rft.issn=1672-0733&rft.volume=32&rft.issue=1&rft.spage=97&rft.epage=102&rft_id=info:doi/10.1007%2Fs11596-012-0017-7&rft.externalDBID=NO_FULL_TEXT | 
    
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg |